CI - Cigna Corporation
After hours:
| Previous close | 242.64 |
| Open | 241.84 |
| Bid | 241.00 x 1000 |
| Ask | 245.25 x 800 |
| Day's range | 241.84 - 248.03 |
| 52-week range | 240.11 - 340.11 |
| Volume | |
| Avg. volume | 1,820,185 |
| Market cap | 73.202B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 11.34 |
| EPS (TTM) | 21.81 |
| Earnings date | 02 Aug 2023 - 07 Aug 2023 |
| Forward dividend & yield | 4.92 (2.03%) |
| Ex-dividend date | 06 Jun 2023 |
| 1y target est | 327.00 |
ZacksCigna Group (CI) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Cigna (CI) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksCI or HUM: Which HMO Stock is Better Placed at the Moment?
Cigna (CI) and Humana (HUM) are well-positioned to expand in the promising HMO space. Let's try to find out which one fares better via comparative evaluation.
ZacksCigna (CI) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cigna (CI) have what it takes? Let's find out.
Business WireAM Best Upgrades Issuer Credit Ratings of The Cigna Group and Most of Its Subsidiaries
OLDWICK, N.J., May 17, 2023--AM Best has upgraded most of the Long-Term Issuer Credit Ratings (Long-Term ICRs) to "a+" (Excellent) from "a" (Excellent) and affirmed the Financial Strength Rating (FSR) of A (Excellent) of the key U.S. life/health subsidiaries, health maintenance organizations and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI]. The outlook of the Long-Term ICRs has been revised to stable from positive while the outlook of t
ZacksCigna Group (CI) Is a Trending Stock: Facts to Know Before Betting on It
Cigna (CI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Yahoo FinanceWhy indie pharmacies, with the help of the likes of Mark Cuban, are on the rise
Independent pharmacies and startups such as Cigna's Express Scripts and Mark Cuban's Cost Plus Drugs are partnering up to address a coverage gap for some Americans.
ZacksThe Zacks Analyst Blog Highlights Eli Lilly, Verizon Communications, United Parcel Service, Advanced Micro Devices and The Cigna Group
Eli Lilly, Verizon Communications, United Parcel Service, Advanced Micro Devices and The Cigna Group are part of the Zacks Analyst Blog.
ZacksTop Stock Reports for Eli Lilly, Verizon Communications & United Parcel Service
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Verizon Communications Inc. (VZ) and United Parcel Service, Inc. (UPS).
ZacksEverQuote (EVER) Q1 Earnings Beat on Lower Operating Expenses
EverQuote (EVER) expects total revenues of $70-$75 million for the second quarter of 2023.
Motley FoolCigna Group (CI) Q1 2023 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by for the Cigna Group's first quarter 2023 results review. With me on the line this morning are David Cordani, the Cigna Group's chairman and chief executive officer; and Brian Evanko, chief financial officer.
ZacksCigna (CI) Q1 Earnings Surpass Estimates, Ups '23 EPS View
Cigna's (CI) first-quarter 2023 results indicate a strong contribution to revenues from Evernorth Health Services and Cigna Healthcare businesses. Management currently expects adjusted EPS to be a minimum of $24.70 in 2023.
ZacksHere's What Key Metrics Tell Us About Cigna (CI) Q1 Earnings
While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- Zacks
Cigna (CI) Surpasses Q1 Earnings and Revenue Estimates
Cigna (CI) delivered earnings and revenue surprises of 3.44% and 2.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ReutersCigna's health insurance strength drives profit forecast raise
(Reuters) -Cigna Group on Friday raised its annual profit forecast after lower medical costs at the company's health insurance business helped it beat estimates in the first quarter, lifting shares 7.5% in morning trade. The health insurer also cut the midpoint of its 2023 medical cost ratio - or spending on claims as a percentage of premiums - by 10 basis points to between 81.5% and 82.3%. Peers including UnitedHealth and Humana also beat profit estimates and raised forecasts this quarter thanks to strength in their government-backed plans and low medical costs.
ZacksThis is Why Cigna (CI) is a Great Dividend Stock
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cigna (CI) have what it takes? Let's find out.
ZacksWhy Earnings Season Could Be Great for Cigna Group (CI)
Cigna Group (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ZacksCan Cigna's (CI) Q1 Earnings Beat on Medical Customers Growth?
The first-quarter results of Cigna (CI) are likely to reflect an expanding customer base and growth in specialty pharmacy services.
ZacksAssurant (AIZ) Surpasses Q1 Earnings and Revenue Estimates
Assurant (AIZ) delivered earnings and revenue surprises of 55.11% and 2.22%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ZacksThe Zacks Analyst Blog Highlights Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins
Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins are included in this Analyst Blog.
ZacksTop Stock Reports for AMD, Cigna & Moderna
Today's Research Daily features new research reports on 12 major stocks, including Advanced Micro Devices, Cigna and Moderna.
ZacksEarnings Preview: Cigna (CI) Q1 Earnings Expected to Decline
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksCigna (CI) Gains But Lags Market: What You Should Know
In the latest trading session, Cigna (CI) closed at $250.33, marking a +0.87% move from the previous day.
ZacksCigna (CI) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Cigna (CI) closed at $252.12, marking a -1.43% move from the previous day.
